Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
Darby Morhardt, PhD, LCSW, research professor in the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease and of Preventive Medicine in the Division of Public Health Practice, was recently appointed to the Illinois Supreme Court Commission on Elder Law.
A Northwestern Medicine study published in Nature Immunology has discovered that mitochondria control the activation of a specific protein complex linked to inflammation and the progression of chronic diseases.
Feinberg’s arts and humanities seminars allow medical students to approach the world of medicine and healthcare from different perspectives and with new skills.
More than 700 alumni and guests convened at this year’s Alumni Weekend to reconnect and reminisce with former classmates about their time at Feinberg and learn about the medical school’s latest developments.
Mary E. Klotman, MD, dean of the Duke University School of Medicine and vice chancellor for Health Affairs at Duke University, will address graduates, parents and guests at Feinberg’s 163rd commencement ceremony on Monday, May 23.
Isabella Salamone, an eighth-year student in the Driskill Graduate Program in Life Sciences, was lead author of a study published in the Journal of Clinical Investigation, which found that glucocorticoid steroids improved muscle performance through distinct, sex-specific molecular pathways.
Enthusiastic attendees gathered in the Feinberg Conference Center at Northwestern Memorial Hospital for the fourth annual Women in Medicine conference on Friday, April 22, which was held in-person for the first time in three years.
Children born to women who took antipsychotic medications later in their pregnancy did not show increased risk of neurodevelopmental disorders, according to a recent study.
Investigators have discovered a novel signaling pathway in interferons that suppresses their anti-tumor response in patients with a particular type of blood cancer.